Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Green Chemistry Division of Minafin to serve as high-value conversion and manufacturing partner, improving downstream supply chain for novel chemistry.
April 20, 2023
By: Anthony Vecchione
Origin Materials, Inc., a carbon negative materials company, and the Green Chemistry Division (GCD) of the Minafin Group, a global fine chemical company, entered into a new commercial arrangement whereby Minafin will become Origin’s manufacturing partner for the downstream supply chain of Origin 1, Origin’s first commercial manufacturing plant. The initiative, which expands on the companies’ previously announced strategic partnership to industrialize sustainable chemicals, aims to further build on Origin’s technology platform, which turns the carbon found in sustainable wood residues into useful materials, and Minafin’s manufacturing capability, supply chain strength, and deep expertise in furanic specialty products. As part of the manufacturing initiative, CMF (chloromethylfurfural) produced by Origin at Origin 1 will be delivered to Minafin, which will convert CMF into downstream intermediates and products. The initiative is expected to position the companies’ complementary technologies to grow the value of the bio-based supply chain for high-value chemicals and materials including bio-based PET (polyethylene terephthalate). “Origin’s expanded relationship with the Green Chemistry Division of Minafin represents a key milestone in our mission to transition the world to sustainable materials,” said Origin Materials Co-CEO Rich Riley. “This partnership strengthens our supply chain at Origin 1, enhances our ability to leverage our versatile platform technology, and supports our commercialization strategy of developing higher-value applications for our intermediates. Minafin’s GCD team offers a valuable skill set and fully integrated capabilities in Memphis, Tennessee, seamlessly linking R&D, scale-up, engineering, and production.” Frederic Gauchet, founder & president Minafin Group said: “We appreciate that the partnership with Origin Materials recognizes the Minafin GCD team, capabilities, and position as a global leader in furanic chemicals and materials. We are delighted to support Origin’s scale-up of their groundbreaking technology for converting biomass to value-added materials. Minafin and Origin Materials are both deeply committed to accelerating the commercialization of bio-based and carbon-negative products to customers worldwide.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !